Perrigo (PRGO) Total Current Liabilities (2013 - 2026)
Perrigo's (PRGO) quarterly Total Current Liabilities came in at $997.6 million in Q1 2026, down 7.1% year-on-year from $1.1 billion in Q1 2025, and down 1.51% on a QoQ basis from $1.0 billion in Q4 2025.
Perrigo (PRGO) Total Current Liabilities (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Total Current Liabilities data on file, last reported at $997.6 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 7.1% year-over-year to $997.6 million in Q1 2026; TTM through Mar 2026 was $997.6 million, a 7.1% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, down 3.0% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $997.6 million, down from $1.0 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for PRGO reached as high as $1.6 billion in Q4 2023 and fell as low as $981.3 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2025.
- Across the five-year window, Total Current Liabilities tumbled 49.35% in 2022 and soared 43.84% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $1.1 billion in 2022, then soared by 42.45% to $1.6 billion in 2023, then sank by 34.17% to $1.0 billion in 2024, then slipped by 3.0% to $1.0 billion in 2025, then declined by 1.51% to $997.6 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $997.6 million in Q1 2026, $1.0 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 997.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 997.60 Mn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 27, 2025 | 1.15 Bn |
| Jun 28, 2025 | 1.13 Bn |
| Mar 29, 2025 | 1.07 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 28, 2024 | 1.45 Bn |
| Jun 29, 2024 | 1.49 Bn |
| Mar 30, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.01 Bn |
| Jul 1, 2023 | 1.06 Bn |
| Apr 1, 2023 | 1.09 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Oct 1, 2022 | 1.02 Bn |
| Jul 2, 2022 | 1.01 Bn |
| Apr 2, 2022 | 981.30 Mn |
| Dec 31, 2021 | 1.59 Bn |
| Oct 2, 2021 | 2.00 Bn |
| Jul 3, 2021 | 1.98 Bn |